 Autoantibodies
"Autoantibodies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them.
| Descriptor ID |
D001323
|
| MeSH Number(s) |
D12.776.124.486.485.114.323 D12.776.124.790.651.114.323 D12.776.377.715.548.114.323
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Autoantibodies".
Below are MeSH descriptors whose meaning is more specific than "Autoantibodies".
This graph shows the total number of publications written about "Autoantibodies" by people in this website by year, and whether "Autoantibodies" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 4 | 3 | 7 | | 1997 | 0 | 2 | 2 | | 1998 | 1 | 2 | 3 | | 1999 | 9 | 3 | 12 | | 2000 | 3 | 1 | 4 | | 2001 | 3 | 4 | 7 | | 2002 | 7 | 3 | 10 | | 2003 | 5 | 4 | 9 | | 2004 | 13 | 11 | 24 | | 2005 | 7 | 9 | 16 | | 2006 | 4 | 7 | 11 | | 2007 | 13 | 8 | 21 | | 2008 | 12 | 8 | 20 | | 2009 | 16 | 17 | 33 | | 2010 | 12 | 9 | 21 | | 2011 | 19 | 7 | 26 | | 2012 | 15 | 9 | 24 | | 2013 | 22 | 10 | 32 | | 2014 | 19 | 8 | 27 | | 2015 | 17 | 20 | 37 | | 2016 | 16 | 9 | 25 | | 2017 | 21 | 21 | 42 | | 2018 | 20 | 11 | 31 | | 2019 | 21 | 16 | 37 | | 2020 | 19 | 13 | 32 | | 2021 | 15 | 18 | 33 | | 2022 | 4 | 47 | 51 | | 2023 | 4 | 49 | 53 | | 2024 | 11 | 14 | 25 | | 2025 | 14 | 16 | 30 | | 2026 | 4 | 7 | 11 |
To return to the timeline, click here.
Below are the most recent publications written about "Autoantibodies" by people in Profiles.
-
Hohsfield KR, Carry P, Slack S, Repaci CT, Vanderlinden LA, Kechris K, Rewers M, Norris JM, Johnson RK. Differences in immune cell profiles around the time of islet autoimmunity seroconversion in children with and without type 1 diabetes. BMJ Open Diabetes Res Care. 2026 May 25; 14(3).
-
Panicker AJ, Hinman SS, Perreau J, Aslanpour A, Williams RL, Steinke S, Quinn E, Hernandez AL, Yandamuri SS, Irani SR, Longbrake EE, O'Connor KC. Generation of Monoclonal Autoantibodies From Myelin Oligodendrocyte Glycoprotein-Specific Human B Cells Using an Optofluidic-Based Platform. Neurol Neuroimmunol Neuroinflamm. 2026 May; 13(3):e200577.
-
Hou S, Lindholm PF, Thurman JM, Lee J, Ramsey-Goldman R, Zhao M. C4b-binding protein as an antigenic target in the pathogenesis of antiphosphatidylethanolamine autoantibodies. Proc Natl Acad Sci U S A. 2026 Mar 24; 123(12):e2528183123.
-
Yang J, Mramba LK, Hård Af Segerstad EM, Kurppa K, Uusitalo U, Aronsson CA, Rewers MJ, McIndoe RA, Toppari J, Ziegler AG, Hagopian WA, Akolkar B, Krischer JP, Norris JM, Virtanen SM, Agardh D. Longitudinal micronutrient exposure reveals country-specific associations with risk of celiac disease in genetically susceptible children: the prospective TEDDY cohort. Am J Clin Nutr. 2026 May; 123(5):101276.
-
Jia X, Zhang C, Waugh K, Miao D, Michels AW, Rewers MJ, Yu L. Identifying Insulin Autoantibodies With Differential Risk in Type 1 Diabetes With a Novel Bridging ELISA. Diabetes. 2026 Mar 01; 75(3):519-525.
-
Germone MM, Nagle SS, Schmiege SJ, Liu Y, Stahl MG, Shull MH, Pan Z, Liu E, Mehta P. Assessment of a standard dietitian evaluation in pediatric patients with celiac disease. Nutrition. 2026 Jul; 147:113169.
-
Qureshi S, Adas M, Cope PJ, Mahfouz H, Bechman K, Deane KD, El-Gabalawy H, Emery P, Finckh A, Gilbert BTP, Holers VM, Isaacs JD, Kastbom A, Mankia K, Mikuls TR, Pratt AG, Rech J, Russell MD, Schett G, Trouw LA, Turesson C, Beers-Tas MHV, van der Helm-van Mil AHM, van Schaardenburg D, van Steenbergen HW, Toes REM, Cope AP, Galloway J, Norton S. Autoantibodies as predictors of progression to rheumatoid arthritis: a systematic review and meta-analysis. RMD Open. 2026 02 11; 12(1).
-
Leiria G, McQueen RB, Jackson C, Rewers M, Hagopian WA, Oram RA, Fieldsend JE, Ferrat LA. Development of a Patient-Level Multi-objective Optimisation Model for Screening Strategies for Childhood Type 1 Diabetes. Pharmacoeconomics. 2026 Apr; 44(4):495-507.
-
Steck AK, Parikh HM, Triolo TM, Ferrat L, You L, Gottlieb PA, Oram RA, Onengut-Gumuscu S, Krischer JP, Rich SS, Redondo MJ. Genetic Risk and Transition Through Preclinical Stages of Type 1 Diabetes. J Clin Endocrinol Metab. 2026 Jan 21; 111(2):e493-e499.
-
Triolo TM, Sosenko JM, Cuthbertson D, Oram RA, Parikh HM, Steck AK, Sims EK, Jacobsen LM, Nathan B, Templeman EL, Onengut-Gumuscu S, Evans-Molina C, Rich SS, Atkinson MA, Redondo MJ. Type 2 Diabetes Genetic Risk and Type 1 Diabetes Heterogeneity and Progression. Diabetes. 2026 01 20; 75(2):389-397.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|